Presepsin levels of patients with Crimean-Congo hemorrhagic fever

Japanese Journal of Infectious Diseases

Volumn 69, Issue 6, 2016, Pages 505-509

  Demirpençe, Özlem ^a   Doǧan, Halef Okan ^a   Erşan, Serpil ^a   Şahin, Mehtap ^a   Şahin, Hasan ^b   Bakır, Mehmet ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Department of Parasitology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; PRESEPSIN; PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLEEDING; BLOOD CLOTTING TEST; BREATHING RATE; CENTRIFUGATION; CRIMEAN CONGO HEMORRHAGIC FEVER; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION AND FOLLOW UP; FEMALE; HEPATOMEGALY; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; PROTHROMBIN TIME; PURPURA; SCORING SYSTEM; SEVERITY GRADING SCORE; SPLENOMEGALY; YOUNG ADULT; BLOOD; CHEMISTRY; DIAGNOSTIC TEST; HEMORRHAGIC FEVER, CRIMEAN; PATHOLOGY; PROCEDURES; SERUM; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTIGENS, CD14; BIOMARKERS; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SERUM; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84996551925     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2015.392     Document Type: Article

References (29)

1. Ergönuä l O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14.
2. Papa A,Weber F,Hewson R,et al. Meeting report: First International Conference on Crimean-Congo hemorrhagic fever. Antiviral Res. 2015;120:57-65.
3. Appannanavar SB,Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis. 2011;3:285-92.
4. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145-60.
5. Swanepoel R,Gill DE,Shepherd AJ,et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11: S794-800.
6. Geisbert TW,Young HA,Jahrling PB,et al. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocyte/macrophages is a key event. J Infect Dis. 2003;188:1618-29.
7. Engin A,Arslan S,Kizildag S,et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect. 2010;12:1071-8.
8. Weber F,Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zoonosis. Cytokine Growth Factor Rev. 2008;19: 395-404.
9. Connolly-Andersen AM,Moll G,Andersson C,et al. Crimean- Congo hemorrhagic fever virus activates endothelial cells. J Virol. 2011;85:7766-74.
10. Mussap M,Noto A,Fravega M,et al. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med. 2011;24: 12-4.
11. Shozushima T,Takahashi G,Matsumoto N,et al. Usefulness of presepsin (sCD14-ST) measurement as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17: 764-9.
12. Bakir M,Engin A,Gozel MG,et al. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012;49:105-10.
13. Zou Q,Wen W,Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5:16-9.
14. Ackland GL,Prowle JR. Presepsin: solving a soluble (CD14) problem in sepsis? Intensive Care Med. 2015;41:351-3.
15. Nockher WA,Bergmann L,Scherberich JE. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol. 1994;98:369-74.
16. Nockher WA,Wick M,Pfister HW. Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis. J Neuroimmunol. 1999;101:161-9.
17. Oesterreicher C,Pfeffel F,Petermann D,et al. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J Hepatol. 1995;23:396-402.
18. Hayashi J,Masaka T,Saito I,et al. Soluble CD14 mediates lipopolysaccharide-induced intercellular adhesion molecule 1 expression in cultured human gingival fibroblasts. Infect Immun. 1996;64:4946-51.
19. Wenisch C,Wenisch H,Parschalk B,et al. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin Exp Immunol. 1996;105:74-8.
20. Geisbert TW,Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004;10:S110-21.
21. Peters CJ,Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med. 2002;30:S268-73.
22. Gul S,Ozturk DB,Kisa U,et al. Procalcitonin levels and its predictive effect on mortality in Crimean-Congo hemorrhagic fever patients. Jpn J Infect Dis. 2015;68:511-3.
23. Ergonul O,Celikbas A,Dokuzoguz B,et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact oral ribavirin therapy. Clin Infect Dis. 2004;39:284-7.
24. Ergonul O,Celikbas A,Baykam N,et al. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006; 12:551-4.
25. Mardani M,Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med. 2007;10:204-14.
26. Tomita M,Yamamoto K,Kobashi H,et al. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology. 1994;20:317-25.
27. Arai Y,Mizugishi K,Nonomura K,et al. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015;21:564-9.
28. Karti SS,Odabasi Z,Korten V,et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-84.
29. Mostafavi E,Pourhossein B,Chinikar S. Clinical symptoms and laboratory findings supporting early diagnosis of Crimean- Congo hemorrhagic fever in Iran. J Med Virol. 2014;86:1188-92.